CoV-2 Controls

CoV-2 IgG Control

CLINIQA Liquid QC™ CoV-2 IgG Control is intended for use as an un-assayed quality control material for SARS-CoV-2 IgG assays. This liquid stable, ready to use, bi-level control is for use with assays designed to produce qualitative results for Covid-19 IgG antibodies to the SARS-CoV-2 spike (S) protein. CLINIQA Liquid QC CoV-2 IgG Control is suitable to objectively monitor the accuracy of testing procedures. Liquid QC CoV-2 IgG Control is intended to simulate negative and positive human patient samples. This control will assist in the evaluation performance of Covid-19 IgG antibody assays.

Liquid, Ready-to-Use for easy storage and long-term performance

CoV-2 Controls Features

True third party control
Assay values available for key diagnostic test systems
Liquid 2–8°C Ready-to-Use for easy storage and long-term performance
3 Vials per level to accommodate multiple test events
2 Levels intended to monitor the accuracy of SARS-CoV-2 Assays
2-year closed, 30-day open stability at 2-8°C
For In-Vitro Diagnostic Use

Contact Us

For Orders & Sales Inquiries: click here to send us an email.